We welcome your email, but please understand that communications via email or through this website do not constitute or create an attorney-client relationship between you and Simon Greenstone Panatier, PC or any of its lawyers. Unless we reach an agreement with regard to representation, the information you provide will not be treated as confidential or privileged, and any such information may be used adversely to you and for the benefit of current or future clients of the law firm.
Erin Anderson Nowell is a shareholder with Simon Greenstone Panatier, PC.
Erin is no stranger to prosecuting claims and defending lawsuits, having spent time on both sides of the courtroom. Directly out of law school, Erin began her career at a nationally recognized plaintiffs’ firm specializing in toxic-tort litigation. There she developed the skills to manage and litigate large-scale mass torts including pharmaceuticals, latex, benzene and asbestos exposure. Erin was responsible for every aspect of the litigation process from initial claim evaluation through investigation and preparation of cases for trial.
In 2007, Erin joined an international defense firm to explore other avenues of litigation. Erin immediately developed an interest in class action litigation. She cultivated significant experience by participating in the defense of several class action cases in federal court including litigation relating to flooding in areas of New Orleans following Hurricane Katrina, consumer fraud statutes, and federal statutes such as the Fair Credit Reporting Act (FCRA).
In early 2010, Erin returned to her roots of helping individuals injured by corporate negligence, indifference, and simple greed. Erin relishes the opportunity to bring about justice for those individuals harmed through no fault of their own. Most importantly, Erin enjoys relieving the burden from clients who have experienced life-changing injuries and loss. Erin’s practice is now focused on individuals injured by their exposure to toxic substances, dangerous products, or the prescribed use of pharmaceuticals.